New Report Details Critical Role of Medical Affairs in Oncology Launch

Sep 21, 2015, 09:55 ET from Best Practices, LLC

CHAPEL HILL, N.C., Sept. 21, 2015 /PRNewswire/ -- A rapidly changing marketplace, coupled with a restricted promotional environment has pushed the Medical Affairs function beyond its traditional support role into a more prominent oncology launch role. From identification and engagement of key thought leaders to guidance of commercial strategies and launch resources management, Medical Affairs plays a vital role in a host of oncology launch activities.

According to recent research by benchmarking firm, Best Practices, LLC, there are four key areas that Medical Affairs must be heavily involved in to promote launch success. These areas include:

  1. Scientific Publications
  2. Continuing Medical Education
  3. Real World Data Generation & Analysis
  4. MSL Activities

Medical Affairs also plays a critical role in internal education and guiding commercial strategies regarding products. This provides Medical Affairs leaders with the opportunity to convey the needs of key decision makers, thus companies to improve their products.

The related report, "Best Practices and the Role of Medical Affairs in Oncology Launch Excellence," evaluates how leading biopharmaceutical companies focused on oncology therapies find better ways to develop successful launch strategies. 

Key study objectives included:

  • Illustrate how Medical Affairs is involved in the launch process in leading Pharma and Biotech companies focused on oncology therapies
  • Highlight strategies for effective thought leader segmentation and relationship management
  • Understand challenges in managing successful Medical Affairs launch support
  • Identify industry drivers regarding new product commercialization
  • Explore critical strategies for allocating Medical Affairs launch budget effectively

This study engaged 11 executives from leading life science companies. Additional deep-dive interviews were conducted with 5 selected Medical Affairs Vice Presidents and Directors. The study analyzes companies that focus on oncology therapies.

To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link:

For more information on other recent primary research studies, contact us at 919.403.0251. For related research, visit our Best Practices, LLC website at

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

SOURCE Best Practices, LLC